What do you need to know about the mRNA vaccine against melanoma?

What do you need to know about the mRNA vaccine against melanoma?

August 26, 2026

By Nicolas Gutierrez C. THE Subscribers

Moderna has announced very positive results for its first mRNA cancer vaccine. Here are five key points to understand this breakthrough.

Melanoma is a rare but very serious skin cancer.

Melanoma is a rare but very serious skin cancer.

Photo by GIRAND / BSIP / BSIP VIA AFP

There promise of mRNA vaccines against cancer It's starting to become a reality. After demonstrating its effectiveness against viral infections (at least in the case of Covid-19), this new technology is now successfully targeting tumors. August 19, 2026, the biotechnology company Moderna, The company that developed one of the most widely used vaccines against the coronavirus has announced very positive results from a phase III trial of a vaccine against melanoma, a very dangerous form of skin cancer. Here are the five main points to remember from this announcement.

The vaccine does not protect against cancer itself, but against recurrence.

Skin cancer RNA vaccine Vaccine Covid-19

en_USEnglish